Sérélys Pharma is a pharmaceutical company specializing in the development and marketing of natural, non-hormonal dietary supplements designed to support individuals through significant hormonal life phases. Based in Monaco, the company was recently acquired by the French pharmaceutical group UPSA in September 2024 to expand into the high-growth women’s wellness sector.

Core Technology and Innovation

Sérélys products are centered around a proprietary, patented technology called CyTonin® Technology.

Active Ingredient:
The technology produces Purified and Specific Cytoplasmic Pollen Extracts.

Process:
It removes the gastro-resistant and potentially allergenic outer shell of pollen grains, leaving only the highly bioavailable cytoplasm.

Safety Profile:
Products are 100% natural and contain no hormones or phytoestrogenic activity, making them a safe alternative for individuals who cannot or do not wish to use conventional hormone replacement therapy (HRT).

Key Products and Applications

The company offers solutions for both women and men, addressing various disorders linked to hormonal upheavals:

Sérélys MENO:
The flagship product and a market leader in Europe for natural menopause care. It is clinically proven to reduce hot flashes, night sweats, irritability, and fatigue.

Sérélys PMS:
Formulated to reduce symptoms of premenstrual syndrome.

Sérélys NIGHT:
Combines pollen extracts to relieve hot flashes and promote restful sleep during menopause.

Sérélys MAN:
Designed for men experiencing symptoms of andropause, such as hot flashes and excessive sweating.

Specialized Health:
Other proprietary products target urinary incontinence (Sérélys Inco-Control), bone health (Sérélys Osteo), and fertility (Sérélys Ferti Man).

Corporate Overview

Headquarters:
5 rue du Gabian, “Le Triton,” Monaco.

Ownership:
Private company, now a subsidiary of UPSA.

Global Presence:
Products are sold in over 50 countries.

Scientific Rigor:
Sérélys formulas are backed by over 30 clinical studies, including large-scale trials with more than 1,000 patients.

Quality Standards:
Manufacturing complies with Good Manufacturing Practices (GMP) and strict French and European regulations.